Excellence Strategy: University of Würzburg Reaches Final Round
08/22/2024The competition for the multi-million euro federal and state funding programme is entering its final phase. JMU has submitted two proposals and the results of the evaluation will be available in May 2025.
About the Research Project „NUCLEATE - Cluster for Nucleic Acid Sciences and Technologies“
NUCLEATE is dedicated to the revolutionary field of nucleic acid research and technologies. The mission of the research network is to harness the potential of nucleic acids towards a new understanding of their role in biology and to pave the way into the field of nucleic acid medicine. NUCLEATE thus pursues a nucleic acid-centred approach with a highly interdisciplinary team.
“As part of NUCLEATE, we are exploring fundamental biological principles and mechanisms of action of nucleic acids in the cell in diverse disease contexts“, explains Würzburg NUCLEATE spokesperson Professor Cynthia Sharma, Chair of Molecular Infection Biology II. “We aim to use these insights to develop new nucleic acid-based biotechnological and biomedical applications.“
“Working together across disciplines at three Bavarian universities and combining our expertise in the field of nucleic acids, strengthens biomedical research in Bavaria in the long term - both nationally and internationally,” emphasises Professor Caroline Kisker, who is coordinating the research project on the Würzburg side together with Professor Sharma and is also a Vice-President of JMU and Chair of Structural Biology. “We are thus paving the way for nucleic acid-based technologies and medicine.” NUCLEATE is a joint Cluster proposal that JMU has submitted together with Ludwig-Maximilians-Universität Munich (LMU) and the Technical University of Munich (TUM).
